Crosscheck

Your medical. Crosschecked.

Check another medication

Testosterone

The FAA's guidance for testosterone depends on how it is taken. Each way is below, with its own FAA source and date.

On the skin (topical) only

FAA guidance

Acceptable with conditions.

Examiner

The examiner can issue when the document's criteria are met

Source: FAA, Low Testosterone (Low T) Hypogonadism. FAA date 29 April 2026. Checked by Crosscheck 14 October 2026

For low testosterone (hypogonadism) treated with topical testosterone only, the FAA's table says that if the examiner can determine the condition is under control, current medications are acceptable, and there are no symptoms that would interfere with flight or safety-related duties, the disposition is to issue and annotate Block 60.

Track your medications
Compare FAA documents: testosteroneWhat each of the two FAA documents says, in plain wordsOpen

Testosterone by mouth or by injection is in the table's row B, with the CACI worksheet.

The FAA's MedGuide names testosterone on the skin (Androderm, Androgel, Fortesta, Jatenzo, Kyzatrex, Natesto, Testim, Tlando, Vogelxo) as allowed, for hormone replacement therapy, hypogonadism, low testosterone and testosterone replacement, with no wait after the first dose, after later doses or after the final dose, used as prescribed. The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.

Show the FAA's words: testosteroneThe official FAA wording: four passages, each with its document and dateOpen
FAA, Low Testosterone (Low T) Hypogonadism · FAA date 29 April 2026
LOW TESTOSTERONE (LOW T) HYPOGONADISM
A. Treated with topical testosterone only
ISSUE
Annotate Block 60.
FAA, Low Testosterone (Low T) Hypogonadism · FAA date 29 April 2026
A. Treated with topical testosterone only
If the AME can determine the condition is under control, current medications are acceptable, and no symptoms that would interfere with flight or safety related duties:
ISSUE
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
Generic: testosterone (topical)
Brand Name: Androderm; Androgel; Fortesta; Jatenzo; Kyzatrex; Natesto; Testim; Tlando; Vogelxo
Drug Class: Testosterone
Underlying Condition: Hormone replacement therapy (HRT); Hypogonadism; Low – testosterone (Low T); Testosterone replacement
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
FAA, MedGuide (FAA Office of Aerospace Medicine medication reference) · FAA date 1 October 2026
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Sources and dates: testosteroneTwo FAA documents, with the FAA's date and when Crosscheck checked themOpen

By mouth or by injection

FAA guidance

Acceptable with conditions.

Examiner

CACI: the examiner can issue when the condition's worksheet criteria are met. Applicants for first- or second-class must provide the worksheet's information annually; applicants for third-class with each required exam

Source: FAA, Low Testosterone (Low T) Hypogonadism. FAA date 29 April 2026. Checked by Crosscheck 14 October 2026

For low testosterone (hypogonadism), the FAA's table lists testosterone taken by mouth or by injection among the treatments of its row B, which goes to the CACI hypogonadism worksheet: it requires a complete blood count (CBC) and a current, detailed clinical progress note from the treating physician or a completed Low T status summary, and the examiner issues if the pilot meets all the CACI worksheet criteria and is otherwise qualified.

Show the FAA's words: testosteroneThe official FAA wording: one passage, each with its document and dateOpen
FAA, Low Testosterone (Low T) Hypogonadism · FAA date 29 April 2026
LOW TESTOSTERONE (LOW T) HYPOGONADISM
B. Treated with one or more of the following:
Anastrozole
Clomiphene citrate
Human Chorionic Gonadotropin (HCG)
Testosterone (Oral or Injectable)
Testopel
Tamoxifen
See the CACI - Hypogonadism Worksheet.
This requires a complete blood count (CBC) lab AND a current, detailed Clinical Progress Note from the treating physician OR a completed Low Testosterone (Low T) Hypogonadism Status Summary
If the pilot meets all CACI worksheet criteria and is otherwise qualified:
ISSUE
Sources and dates: testosteroneOne FAA document, with the FAA's date and when Crosscheck checked itOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.